rs114232513

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_033305.3(VPS13A):​c.6410A>G​(p.Glu2137Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000989 in 1,568,116 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E2137E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0053 ( 8 hom., cov: 31)
Exomes 𝑓: 0.00053 ( 4 hom. )

Consequence

VPS13A
NM_033305.3 missense

Scores

10
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.89

Publications

4 publications found
Variant links:
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
VPS13A Gene-Disease associations (from GenCC):
  • chorea-acanthocytosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00822413).
BP6
Variant 9-77339547-A-G is Benign according to our data. Variant chr9-77339547-A-G is described in ClinVar as Benign. ClinVar VariationId is 367401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00532 (805/151224) while in subpopulation AFR AF = 0.0184 (760/41240). AF 95% confidence interval is 0.0173. There are 8 homozygotes in GnomAd4. There are 394 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VPS13ANM_033305.3 linkc.6410A>G p.Glu2137Gly missense_variant Exon 48 of 72 ENST00000360280.8 NP_150648.2 Q96RL7-1
VPS13ANM_001018037.2 linkc.6293A>G p.Glu2098Gly missense_variant Exon 47 of 71 NP_001018047.1 Q96RL7-3
VPS13ANM_015186.4 linkc.6410A>G p.Glu2137Gly missense_variant Exon 48 of 69 NP_056001.1 Q96RL7-2
VPS13ANM_001018038.3 linkc.6410A>G p.Glu2137Gly missense_variant Exon 48 of 69 NP_001018048.1 Q96RL7-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VPS13AENST00000360280.8 linkc.6410A>G p.Glu2137Gly missense_variant Exon 48 of 72 1 NM_033305.3 ENSP00000353422.3 Q96RL7-1
VPS13AENST00000376636.7 linkc.6293A>G p.Glu2098Gly missense_variant Exon 47 of 71 1 ENSP00000365823.3 Q96RL7-3
VPS13AENST00000643348.1 linkc.6410A>G p.Glu2137Gly missense_variant Exon 48 of 69 ENSP00000493592.1 Q96RL7-2
VPS13AENST00000645632.1 linkc.6410A>G p.Glu2137Gly missense_variant Exon 48 of 69 ENSP00000496361.1 Q96RL7-4

Frequencies

GnomAD3 genomes
AF:
0.00533
AC:
806
AN:
151112
Hom.:
8
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0185
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00198
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000884
Gnomad OTH
AF:
0.00432
GnomAD2 exomes
AF:
0.00134
AC:
251
AN:
186742
AF XY:
0.000998
show subpopulations
Gnomad AFR exome
AF:
0.0189
Gnomad AMR exome
AF:
0.000742
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000391
Gnomad OTH exome
AF:
0.000792
GnomAD4 exome
AF:
0.000527
AC:
746
AN:
1416892
Hom.:
4
Cov.:
35
AF XY:
0.000422
AC XY:
296
AN XY:
700960
show subpopulations
African (AFR)
AF:
0.0182
AC:
585
AN:
32136
American (AMR)
AF:
0.000956
AC:
36
AN:
37656
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25298
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37330
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81108
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51282
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5694
European-Non Finnish (NFE)
AF:
0.0000368
AC:
40
AN:
1087666
Other (OTH)
AF:
0.00133
AC:
78
AN:
58722
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.401
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00532
AC:
805
AN:
151224
Hom.:
8
Cov.:
31
AF XY:
0.00534
AC XY:
394
AN XY:
73780
show subpopulations
African (AFR)
AF:
0.0184
AC:
760
AN:
41240
American (AMR)
AF:
0.00198
AC:
30
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4764
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10316
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000885
AC:
6
AN:
67834
Other (OTH)
AF:
0.00428
AC:
9
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
37
73
110
146
183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00215
Hom.:
4
Bravo
AF:
0.00623
ESP6500AA
AF:
0.0127
AC:
56
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00135
AC:
162

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 31, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Chorea-acanthocytosis Benign:2
Nov 11, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.41
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.62
.;.;D;.;.;.;D
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.95
.;D;.;.;D;D;D
MetaRNN
Benign
0.0082
T;T;T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.5
M;.;M;M;M;M;M
PhyloP100
4.9
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-4.3
D;D;D;D;.;.;.
REVEL
Benign
0.23
Sift
Uncertain
0.0030
D;D;D;D;.;.;.
Sift4G
Uncertain
0.0060
D;D;D;D;.;.;.
Polyphen
0.36
B;B;B;B;B;B;B
Vest4
0.34
MVP
0.71
MPC
0.39
ClinPred
0.071
T
GERP RS
5.9
Varity_R
0.23
gMVP
0.55
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114232513; hg19: chr9-79954463; API